Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

BACKGROUND: The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM) should be considered in the unique context of malignant brain tumours. Although patients benefit greatly from reduced cerebral oedema and intracranial pressure, this important clinical improvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeff, Joost JC, van Tellingen, Olaf, Claes, An, Stalpers, Lukas JA, van Linde, Myra E, Richel, Dirk J, Leenders, William PJ, van Furth, Wouter R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801683/
https://www.ncbi.nlm.nih.gov/pubmed/20015387
http://dx.doi.org/10.1186/1471-2407-9-444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801683/
https://www.ncbi.nlm.nih.gov/pubmed/20015387
http://dx.doi.org/10.1186/1471-2407-9-444

Ejemplares similares